Holen Sie sich die Stockscreener-App
389.04
3.97%
14.86
Handel nachbörslich:
390.04
1.00
+0.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$374.18
Offen:
$397.22
24-Stunden-Volumen:
21.36M
Relative Volume:
2.11
Marktkapitalisierung:
$486.52B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
73.43
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
+7.32%
1M Leistung:
+39.96%
6M Leistung:
+136.21%
1J Leistung:
+321.77%
1-Tages-Spanne:
$386.90
$401.00
1-Wochen-Bereich:
$354.89
$401.00
52-Wochen-Spanne:
$87.75
$401.00
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
389.04 | 467.94B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,929.68 | 719.89B | 39.08B | 11.61B | 9.94B | 30.00 |
AMAT
Applied Materials Inc
|
617.11 | 470.75B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
259.56 | 311.85B | 13.09B | 4.67B | 4.01B | 35.37 |
TER
Teradyne Inc
|
437.92 | 63.96B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research Corp (LRCX) Shares Surge 4.0% -- What GF Score of 8 - GuruFocus
Lam Research Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Allegro MicroSystems, Lam Research, and Applied Materials Shares Are Soaring, What You Need To Know - Yahoo Finance
Are You Looking for a Top Momentum Pick? Why Lam Research (LRCX) is a Great Choice - Yahoo Finance Singapore
Lam Research Corp Stock (LRCX) Moved Up by 6.52% on Jun 18: Key Drivers Unveiled - TradingKey
Renaissance Investment Management Expects Positive Upward Revision for Lam Research (LRCX) - Yahoo Finance
Investment Management Corp of Ontario Raises Stock Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation (LRCX)’s WFE Opportunity May Be Bigger Than Expected - Insider Monkey
Alight Capital Management LP Increases Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research (LRCX) Receives a Price Target Boost at Barclays. Here is Why - Yahoo Finance
Citigroup Adjusts Price Target on Lam Research to $450 From $315, Maintains Buy Rating - Moomoo
Lam Research Corp (LRCX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
This Memory Stock Has Doubled in 2026. Here's Why It Can Skyrocket Higher (Hint: It's Not Micron or Sandisk) - The Motley Fool
Lam Research Corp Stock (LRCX) Moved Up by 4.86% on Jun 17: A Full Analysis - TradingKey
Lam Research (NASDAQ:LRCX) Given New $420.00 Price Target at Rothschild & Co Redburn - MarketBeat
Lam Research Corporation $LRCX Shares Sold by State of Wisconsin Investment Board - MarketBeat
Night Squared LP Cuts Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp (LRCX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lam Research Corp (LRCX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lam Research Corp (LRCX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Carret Asset Management LLC Sells 5,158 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Captrust Financial Advisors - MarketBeat
Fullerton Fund Management Co Ltd. Purchases Shares of 2,728 Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp (LRCX) Institutional Confidence - TradingKey
Lam Research (LRCX) Research Report - StockStory
Lam Research Target of Unusually High Options Trading (NASDAQ:LRCX) - MarketBeat
Unusual Put Options Activity in Lam Research Stock Highlights Its Value - Barchart.com
Lam Research Corp Stock (LRCX) Moved Down by 3.29% on Jun 16: What Signal Does It Send? - TradingKey
Lam Research (LRCX) Stands Out on Strong Demand - Insider Monkey
Lam Research Expects Packaging Growth of 50%: Is It a Hidden Catalyst? - Yahoo Finance UK
OMERS ADMINISTRATION Corp Has $14.42 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Alphabet, Lam Research, A Financial Stock: CNBC’s ‘Final Trades’Alphabet (NASDAQ:GOOG), Alphabet (NASD - Benzinga
Lam Research director Eric Brandt sells $20.01m in company shares - Investing.com Canada
Lam Research Corp. stock underperforms Monday when compared to competitors despite daily gains - MSN
A Look at Lam Research Corp (LRCX) After 6.0% Gain -- GF Value $129.43 vs Price $388.92 - GuruFocus
Lam Research director Eric Brandt sells $19.1 million in common stock By Investing.com - Investing.com Australia
Lam Research director Eric Brandt sells $19.1 million in common stock - Investing.com Nigeria
Is Lam Research (LRCX) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance Singapore
Lam Research Corp Stock (LRCX) Moved Up by 5.90% on Jun 15: What Signal Does It Send? - TradingKey
Oppenheimer Adjusts Price Target on Lam Research to $400 From $330, Maintains Outperform Rating - Moomoo
The Zacks Analyst Blog Highlights Costco, Lam Research, KLA, Blue Ridge and AXIL - Zacks Investment Research
Entropy Technologies LP Sells 19,084 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp (LRCX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apriem Advisors Has $15.74 Million Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research (LRCX) Stock Fair Value Edges Higher After Analyst Target Increases - Yahoo Finance
Lam Research Corporation $LRCX Stock Position Decreased by Van ECK Associates Corp - MarketBeat
Korea Investment CORP Cuts Stock Position in Lam Research Corporation $LRCX - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
LRCX News | LAM RESEARCH CORP (NASDAQ:LRCX) - ChartMill
Top analyst reports for Costco, Lam Research & KLA - MSN
Lam Research (NASDAQ:LRCX) Trading 1.2% HigherWhat's Next? - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):